分子靶向药物在结直肠癌治疗方面的研究进展  

Progress in Research on Molecular Target Drug in Colorectal Cancer Therapy

作　　者：赵巍[1] 陈焕[1] 冯业童[2] 刘朋飞[2] 

机构地区：[1]大庆龙南医院物理诊断科,黑龙江大庆163453 [2]吉林大学药学院生物工程实验中心,长春130021

出　　处：《医学综述》2012年第9期1322-1324,共3页Medical Recapitulate

摘　　要：在消化系统中,结直肠癌是常见的恶性肿瘤,并且其发病率日渐提高。以手术为主,结合化疗、放疗的综合治疗方法,是结直肠癌的主要治疗模式,在过去和现在均发挥着不可替代的作用,但该治疗方法自身的弊端也不容忽视。而分子靶向药物的出现为结直肠等肿瘤的治疗开辟了一个新方向,该药物在临床及临床前研究均取得了一定成果,已成为结直肠癌治疗的一条新途径。在此就近些年来分子靶向药物在结直肠癌治疗方面的相关进展予以综述。Colorectal cancer is a kind of frequentey seen malignant tumors in digestive system with growing incidence.Operation with chemotherapy and radiotherapy is used as the main therapy for the cancer,which has significant function in the past and present time.However,the problems of this mode should not be ignored.Anyway,a new direction is established with the appearance of molecular target drug for tumor therapy.With lots of clinical and preclinical research,this drug has been a new therapy for colorectal cancer.Here is to make a review on the progress in recent years in research of molecular target drug in colorectal cancer therapy.

关 键 词：分子靶向药物 结直肠癌 靶向治疗 

分 类 号：R574.6[医药卫生—消化系统]